Inactive Instrument

All News GlaxoSmithKline plc London S.E.

Equities

End-of-day quote London S.E. Other stock markets
- ^GBX	-

04:26pm	GSK Says Depemokimab Reduced Asthma Attacks in 2 Late-Stage Studies	MT
02:03pm	GSK's Potential Blockbuster Asthma Drug Shows Promise in Latest Trial -- 2nd Update	DJ

GSK Says Depemokimab Reduced Asthma Attacks in 2 Late-Stage Studies	10:26am	MT
GSK announces positive results from phase III severe asthma trials of depemokimab \| GSK	09:55am	AQ
GSK's Potential Blockbuster Asthma Drug Shows Promise in Latest Trial -- 2nd Update	08:03am	DJ
News Highlights : Top Company News of the Day - Tuesday at 7 AM ET	07:18am	DJ
GSK Potential Blockbuster Asthma Drug Shows Promise in Latest Trial -- Update	06:20am	DJ
GSK : announces positive results from phase III severe asthma trials of depemokimab - Form 6-K	06:19am	PU
GSK: positive results for depemokimab in severe asthma	03:56am	CF
GSK's depemokimab asthma treatment meets endpoints in latest trials	03:50am	AN
GSK's experimental drug shows promise in reducing severe asthma attacks	03:29am	RE
GSK's Asthma Drug Reduces Severe Attacks in Late-stage Studies	02:58am	MT
GSK Sees Positive Results for Severe Asthma Treatment Depemokimab	02:33am	DJ
GSK's asthma drug shows promise in reducing severe attacks	02:24am	RE
GSK Reports Positive Phase III Asthma Results For Depemokimab	02:20am	RE
AstraZeneca aims for $80 bln in total revenue by 2030	02:18am	RE
GSK Faces Whistleblower Lawsuit for Allegedly Hiding Antacid Zantac's Cancer Risks	12:33am	MT
GSK faces whistleblower lawsuit over Zantac cancer risk	05-20	RE
Lab at Heart of Zantac Cancer Claims Files Whistleblower Lawsuit Against GSK	05-20	MT
GSK executive buys GBP20,026 worth shares	05-20	AN
UK's FTSE 100 Closes Lower Amid Inflation Focus	05-17	MT
Marti Technologies Hires Oguz Erkan as CFO	05-17	MT

No results for this search

GSK plc : Back on track

May 03, 2024 at 05:17 am

GSK PLC : Encouraging start to 2024; guidance raised